C-Rad AB (LTS:0R44) Operating Margin %: 11.46% (As of Mar. 2026) — 41% Above Median


LTS:0R44 C-Rad AB LTS:0R44
83 GF Score
Price kr35.90
GF Value kr33.44
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is C-Rad AB Operating Margin %?

C-Rad AB LTS:0R44 83 Operating Margin % is 11.46% as of Mar. 2026, which is 41% above its 10-year median of 8.14. GuruFocus rates LTS:0R44 with a GF Score™ of 83/100 and a GF Value™ of kr33.44 (Fairly Valued). The stock has 4 warning signs investors should review. Among 816 Medical Devices & Instruments companies, C-Rad AB ranks better than 68.38% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. C-Rad AB's Operating Income for the three months ended in Mar. 2026 was kr12.0 Mil. C-Rad AB's Revenue for the three months ended in Mar. 2026 was kr104.7 Mil. Therefore, C-Rad AB's Operating Margin % for the quarter that ended in Mar. 2026 was 11.46%.

Good Sign:

C-Rad AB operating margin is expanding. Margin expansion is usually a good sign.

The historical rank and industry rank for C-Rad AB's Operating Margin % or its related term are showing as below:

LTS:0R44' s Operating Margin % Range Over the Past 10 Years
Min: -36.95   Med: 8.14   Max: 15.02
Current: 11.05


LTS:0R44's Operating Margin % is ranked better than
68.38% of 816 companies
in the Medical Devices & Instruments industry
Industry Median: 3.465 vs LTS:0R44: 11.05

C-Rad AB's 5-Year Average Operating Margin % Growth Rate was 8.20% per year.

C-Rad AB's Operating Income for the three months ended in Mar. 2026 was kr12.0 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was kr47.3 Mil.


C-Rad AB  (LTS:0R44) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


C-Rad AB Operating Margin % Related Terms


C-Rad AB Operating Margin % Historical Data

* Premium members only.

The historical data trend for C-Rad AB's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

C-Rad AB Operating Margin % Chart

C-Rad AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.00 7.22 11.73 15.02 13.72

C-Rad AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.50 8.08 19.07 5.10 11.46

LTS:0R44 vs ABT, SYK, MDT: Operating Margin % Comparison

For the Medical Devices subindustry, C-Rad AB's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


C-Rad AB Operating Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, C-Rad AB's Operating Margin % distribution charts can be found below:

* The bar in red indicates where C-Rad AB's Operating Margin % falls into.


LTS:0R44
83GF Score
C-Rad AB LTS:0R44
Operating Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

C-Rad AB Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

C-Rad AB's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (A: Dec. 2025 ) / Revenue (A: Dec. 2025 )
=60.639 / 441.903
=13.72 %

C-Rad AB's Operating Margin % for the quarter that ended in Mar. 2026 is calculated as

Operating Margin %=Operating Income (Q: Mar. 2026 ) / Revenue (Q: Mar. 2026 )
=12 / 104.7
=11.46 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of 11.46% mean?
C-Rad AB (LTS:0R44) has a Operating Margin % of 11.46% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on C-Rad AB and its competitors. This is 41% above median its historical median of 8.14. According to the industry distribution chart, C-Rad AB ranks #258 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 31.6%.
Is C-Rad AB's Operating Margin % too high?
C-Rad AB's current Operating Margin % of 11.46% is 41% above median its 10-year median of 8.14. The Medical Devices & Instruments industry median Operating Margin % is 3.47. C-Rad AB's value of 11.46% is 230.7% above this industry median. Based on the distribution chart, C-Rad AB ranks #258 out of 816 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, C-Rad AB has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does C-Rad AB's Operating Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, C-Rad AB ranks #258 out of 816 companies for Operating Margin %. This puts C-Rad AB in the upper half of its industry. The industry median Operating Margin % is 3.47. C-Rad AB's value of 11.46% is 230.7% above this benchmark. While the company's 10-year median is 8.14 vs. the industry median of 3.47, C-Rad AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Devices & Instruments company?
The median Operating Margin % among Medical Devices & Instruments companies is 3.47, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. C-Rad AB's current Operating Margin % of 11.46% is 230.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on C-Rad AB and its competitors. For the Medical Devices & Instruments industry, the median Operating Margin % is 3.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. C-Rad AB's current Operating Margin % is 11.46%, which is 41% above median its own 10-year median of 8.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is C-Rad AB stock overvalued right now?
Based on GuruFocus' analysis, C-Rad AB (LTS:0R44) is currently considered Fairly Valued. The stock's GF Value™ is kr33.44, compared to a current price of kr35.90 — trading 7.4% above its estimated fair value. The current Operating Margin % is 11.46%, which is 41% above median its 10-year median of 8.14 and 230.7% above the Medical Devices & Instruments industry median of 3.47. C-Rad AB's overall GF Score™ is 83/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For C-Rad AB (LTS:0R44), the current Operating Margin % is 11.46% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is C-Rad AB (LTS:0R44) Overvalued in 2026?

Based on GuruFocus' analysis, C-Rad AB stock appears to be overvalued. The current stock price of kr35.90 is trading 7.4% above its estimated GF Value™ of kr33.44. GuruFocus considers C-Rad AB to be Fairly Valued.

Key valuation signals for LTS:0R44:

  • Operating Margin %: 11.46% (41% above median its 10-year median of 8.14)
  • GF Value™: kr33.44 vs. price of kr35.90 (7.4% above fair value)
  • GF Score™: 83/100 with 4 warning signs
  • Industry Position: 230.7% above the Medical Devices & Instruments median (#258 of 816)

No single metric tells the full story. See the LTS:0R44 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


C-Rad AB Business Description

Other Exchanges CRAD B:Sweden24C:Germany
Address Sjukhusvagen 12K, Uppsala, SWE, 753 09
C-Rad AB is a Sweden-based company engaged in the development and sales of systems with applications in radiation therapy for the treatment of cancer. The systems can be used to position the patient before the treatment and to localize and monitor the tumor by recording information such as patient movements during radiation treatment. Its product portfolio includes the Catalyst and Sentinel systems. Geographically, the company generates a majority of its revenue from Asia Pacific region, and also has its presence in Europe, Middle East and Africa and the rest from Americas.
83GF Score

Get the complete analysis for LTS:0R44

Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr35.90
Price
kr33.44
GF Value